PapersFlow Research Brief
Cardiac electrophysiology and arrhythmias
Research Guide
What is Cardiac electrophysiology and arrhythmias?
Cardiac electrophysiology and arrhythmias is the study of electrical activity in the heart, including the molecular mechanisms, ion channel functions, and clinical manifestations of rhythm disorders such as atrial fibrillation, Long-QT Syndrome, Brugada Syndrome, and sudden cardiac death.
This field encompasses 150,376 published works focused on ion channels, calcium signaling, genetic testing, and arrhythmogenic remodeling in the heart. Key investigations include the initiation of atrial fibrillation by ectopic beats from pulmonary veins, as shown in 'Spontaneous Initiation of Atrial Fibrillation by Ectopic Beats Originating in the Pulmonary Veins' (Haïssaguerre et al., 1998). Prophylactic defibrillator implantation reduces mortality in patients with myocardial infarction and reduced ejection fraction, per 'Prophylactic Implantation of a Defibrillator in Patients with Myocardial Infarction and Reduced Ejection Fraction' (Moss et al., 2002).
Topic Hierarchy
Research Sub-Topics
Long-QT Syndrome Genetics
This sub-topic focuses on the identification of KCNQ1, KCNH2, and SCN5A mutations causing Long-QT Syndrome, along with genotype-phenotype correlations and genetic testing protocols. Researchers study polygenic risk factors and novel variants through large cohort sequencing.
Brugada Syndrome Ion Channelopathies
Studies examine SCN5A loss-of-function mutations and sodium channel dysfunction in Brugada Syndrome, including electrophysiological mechanisms and fever-induced arrhythmogenesis. Research integrates animal models with human induced pluripotent stem cell studies.
Cardiac Ryanodine Receptor Dysfunction
This area investigates RYR2 mutations and leaky calcium release channels causing catecholaminergic polymorphic ventricular tachycardia and arrhythmogenic remodeling. Researchers explore post-translational modifications and therapeutic stabilizers.
Arrhythmogenic Ion Channel Remodeling
Research analyzes downregulation of potassium and sodium channels in heart failure, atrial fibrillation, and post-infarct substrates that promote reentry circuits. Studies use computational modeling and single-cell electrophysiology to quantify remodeling.
Calcium Signaling in Cardiac Arrhythmias
This sub-topic covers spatiotemporal calcium dynamics, store overload, and triggered activity in ventricular and atrial arrhythmias. Researchers employ high-resolution imaging and optogenetics to dissect sarcoplasmic reticulum-mitochondria interactions.
Why It Matters
Cardiac electrophysiology and arrhythmias research directly informs treatments that extend survival in high-risk patients. 'Prophylactic Implantation of a Defibrillator in Patients with Myocardial Infarction and Reduced Ejection Fraction' (Moss et al., 2002) established that defibrillators improve survival in patients with prior myocardial infarction and advanced left ventricular dysfunction. 'Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart Failure' (Bardy et al., 2005) demonstrated that single-lead ICD therapy reduces overall mortality by 23 percent in NYHA class II or III CHF patients with LVEF ≤35 percent, compared to amiodarone. 'Spontaneous Initiation of Atrial Fibrillation by Ectopic Beats Originating in the Pulmonary Veins' (Haïssaguerre et al., 1998) identified pulmonary veins as foci treatable by radio-frequency ablation, guiding catheter-based interventions. Recent advancements include Volta Medical's €36M funding for AI-assisted electrophysiology in atrial fibrillation treatment and FDA Breakthrough Device Designation for Rhythio Medical’s injectable hydrogel electrode for minimally invasive arrhythmia management.
Reading Guide
Where to Start
'Spontaneous Initiation of Atrial Fibrillation by Ectopic Beats Originating in the Pulmonary Veins' (Haïssaguerre et al., 1998) is the ideal starting paper because it provides a foundational clinical observation of arrhythmia triggers with direct therapeutic implications, accessible via its NEJM publication and 7866 citations.
Key Papers Explained
'Spontaneous Initiation of Atrial Fibrillation by Ectopic Beats Originating in the Pulmonary Veins' (Haïssaguerre et al., 1998) identifies pulmonary vein ectopics as AF initiators, building the basis for ablation therapies. 'Prophylactic Implantation of a Defibrillator in Patients with Myocardial Infarction and Reduced Ejection Fraction' (Moss et al., 2002) extends this to ventricular protection via ICDs in post-MI patients. 'Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart Failure' (Bardy et al., 2005) compares ICD superiority over amiodarone in heart failure, reducing mortality by 23 percent. 'Prevalence of Diagnosed Atrial Fibrillation in Adults' (Go et al., 2001) quantifies disease burden, informing trial designs. 'Cardiac-Resynchronization Therapy with or without an Implantable Defibrillator in Advanced Chronic Heart Failure' (Bristow et al., 2004) integrates resynchronization with defibrillation for QRS-prolonged heart failure.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Current frontiers emphasize AI integration in electrophysiology procedures, as in Heart Rhythm 2025 research on AI for procedural safety and Volta Medical's €36M-funded AI for atrial fibrillation treatment. Experimental models for arrhythmia research are reviewed in the ESC working group position paper on cardiac cellular electrophysiology. FDA granted Breakthrough Device Designation to Rhythio Medical’s hydrogel electrode for minimally invasive arrhythmia management.
Papers at a Glance
| # | Paper | Year | Venue | Citations | Open Access |
|---|---|---|---|---|---|
| 1 | Spontaneous Initiation of Atrial Fibrillation by Ectopic Beats... | 1998 | New England Journal of... | 7.9K | ✓ |
| 2 | Prophylactic Implantation of a Defibrillator in Patients with ... | 2002 | New England Journal of... | 6.8K | ✓ |
| 3 | Amiodarone or an Implantable Cardioverter–Defibrillator for Co... | 2005 | New England Journal of... | 6.5K | ✓ |
| 4 | Prevalence of Diagnosed Atrial Fibrillation in Adults | 2001 | JAMA | 6.2K | ✕ |
| 5 | Cardiac-Resynchronization Therapy with or without an Implantab... | 2004 | New England Journal of... | 5.8K | ✕ |
| 6 | Effect of metoprolol CR/XL in chronic heart failure: Metoprolo... | 1999 | The Lancet | 5.1K | ✕ |
| 7 | Edoxaban versus Warfarin in Patients with Atrial Fibrillation | 2013 | New England Journal of... | 5.0K | ✓ |
| 8 | The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a ra... | 1999 | The Lancet | 4.9K | ✕ |
| 9 | Cardiac excitation–contraction coupling | 2002 | Nature | 4.6K | ✕ |
| 10 | Cardiac Resynchronization in Chronic Heart Failure | 2002 | New England Journal of... | 4.6K | ✓ |
In the News
Gilde Healthcare company Volta medical secures €36M in ...
Volta Medical, a pioneering health technology company developing artificial intelligence (AI) solutions to assist electrophysiologist physicians in treating complex cardiac arrhythmias such as atri...
Heart Rhythm Treatment Gets Breakthrough FDA Designation
The U.S. Food and Drug Administration recently granted Breakthrough Device Designation to Rhythio Medical’s injectable hydrogel electrode technology, a minimally invasive approach to managing heart...
Landmark Canadian-led trial finds many atrial fibrillation ...
OCEAN was supported by Bayer, Abbott, Biotronik, the Canadian Institutes for Health Research (CIHR), the University of Ottawa Heart Institute Accelerate Funding Program, the Canadian Stroke Prevent...
Heart Rhythm 2025 Features Advances in AI that Enhance ...
**SAN DIEGO, CA, APRIL 24, 2025**– Today, the Heart Rhythm Society (HRS) unveiled new research that underscores the critical role of artificial intelligence (AI) in improving procedural safety in c...
Johnson & Johnson Initiates CORE-VA Registry to ...
**Irvine, CA –October 10, 2025**– Johnson & Johnson MedTech, a global leader in cardiac arrhythmia treatment, in collaboration with the Heart Rhythm Clinical and Research Solutions, LLC., introduce...
Code & Tools
This repository provides a unified framework for training and evaluating electrocardiogram–language models (ELMs). It is intended for researchers d...
image cbcbeat is a collection of Python-based solvers for cardiac electrophysiology models. cbcbeat offers basic and optimized solvers for the bid...
Library for running cardiac electrophysiology simulations. - Source code: https://github.com/finsberg/fenics-beat - Documentation: https://finsbe...
Myokit is a tool for modeling and simulation of cardiac cellular electrophysiology. It's open-source , written in Python, hosted on GitHub and avai...
- Electrophysiology: defines how the cellular and propagation modules interact. - Electrocardiogram: is responsible for calculating and processing ...
Recent Preprints
JACC: Clinical Electrophysiology
Topic Collections Arrhythmia Diagnosis & Monitoring Atrial Arrhythmia Atrial Fibrillation Basic & Translational Research Cardiac Pacing Cerebrovascular Disease & Stroke Cong...
Arrhythmias - Latest research and news
Arrhythmias are conditions in which electrical impulses are abnormally conducted through the heart, resulting in an altered heart beat muscle contraction rhythm. These alterations to heart beat r...
ESC Journals | Comprehensive Cardiovascular Library
EP Europace publishes high‑quality European and international research and reviews on arrhythmias, pacing, and cellular electrophysiology. The journal features peer‑reviewed original papers, invite...
ESC working group on cardiac cellular electrophysiology position paper: relevance, opportunities, and limitations of experimental models for cardiac electrophysiology research
Cardiac Cellular Electrophysiology provides an overview of (1) currently available in vitro, ex vivo and in vivo electrophysiological research methodologies, (2) the most commonly used experimenta...
(PDF) Cardiac Arrhythmias and Their Management: An In- ...
understanding and promote advancements in the field, ultimately improving patient outcomes with cardiac arrhythmias. Categories: Internal Medicine, Medical Education, Medical Simulation Keywords...
Latest Developments
Recent developments in cardiac electrophysiology and arrhythmias research include advancements in ablation techniques such as pulsed field ablation for persistent atrial fibrillation, which shows promising 1-year outcomes with high success rates and safety (JACC, 2025), as well as innovations like leadless pacemakers and the Amplatzer Amulet implant for stroke prevention (Circulation, 2024, CVRTI). Additionally, artificial intelligence is being increasingly applied to personalize atrial fibrillation treatment (Nature Medicine, 2025; Nature, 2025). The upcoming Heart Rhythm 2026 conference in April will showcase further innovations and collaborative efforts in the field (HRS, 2026).
Sources
Frequently Asked Questions
What initiates atrial fibrillation?
Ectopic beats originating in the pulmonary veins trigger frequent paroxysms of atrial fibrillation, as identified in 'Spontaneous Initiation of Atrial Fibrillation by Ectopic Beats Originating in the Pulmonary Veins' (Haïssaguerre et al., 1998). These foci respond to radio-frequency ablation treatment. The study analyzed 45 patients with paroxysmal atrial fibrillation.
How do defibrillators benefit post-myocardial infarction patients?
Prophylactic implantation of a defibrillator improves survival in patients with prior myocardial infarction and reduced ejection fraction, according to 'Prophylactic Implantation of a Defibrillator in Patients with Myocardial Infarction and Reduced Ejection Fraction' (Moss et al., 2002). This therapy is recommended for those with advanced left ventricular dysfunction. The trial involved patients with specific ejection fraction criteria.
What is the prevalence of atrial fibrillation in adults?
Atrial fibrillation prevalence is common among older adults in the United States, with estimates likely to increase 2.5-fold over the next 50 years, as reported in 'Prevalence of Diagnosed Atrial Fibrillation in Adults' (Go et al., 2001). The study provides a contemporary basis for these projections. It reflects the growing proportion of elderly populations.
How effective is ICD therapy in heart failure?
In NYHA class II or III congestive heart failure patients with LVEF ≤35 percent, single-lead shock-only ICD therapy reduces overall mortality by 23 percent, while amiodarone shows no survival benefit, per 'Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart Failure' (Bardy et al., 2005). This outcome supports ICD use over antiarrhythmic drugs. The trial compared these interventions directly.
What role do pulmonary veins play in arrhythmias?
Pulmonary veins serve as a primary source of ectopic beats that initiate atrial fibrillation paroxysms, treatable by ablation, as detailed in 'Spontaneous Initiation of Atrial Fibrillation by Ectopic Beats Originating in the Pulmonary Veins' (Haïssaguerre et al., 1998). Mapping confirmed these foci in frequent cases. Radio-frequency ablation targets them effectively.
Open Research Questions
- ? What molecular pathways underlie arrhythmogenic ion-channel remodeling in Long-QT and Brugada Syndromes?
- ? How can genetic testing optimize risk stratification for sudden cardiac death?
- ? What are the long-term outcomes of pulmonary vein isolation ablation beyond initial ectopic beat suppression?
- ? How do calcium signaling disruptions via ryanodine receptors contribute to ventricular arrhythmias?
- ? Which patient subgroups derive maximal survival benefit from prophylactic ICD implantation?
Recent Trends
Recent developments feature AI advancements, including Heart Rhythm 2025 presentations on AI enhancing cardiac electrophysiology procedural safety and Volta Medical securing €36M for AI solutions in atrial fibrillation treatment.
FDA awarded Breakthrough Device Designation to Rhythio Medical’s injectable hydrogel electrode technology for heart rhythm management.
Preprints highlight experimental models in cardiac cellular electrophysiology from the ESC working group and ongoing topics in JACC: Clinical Electrophysiology such as arrhythmia diagnosis, atrial fibrillation, and basic research.
Research Cardiac electrophysiology and arrhythmias with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Cardiac electrophysiology and arrhythmias with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers